Catalyst Funds Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,700
Closed -$112K 1039
2024
Q3
$112K Buy
6,700
+1,600
+31% +$34.4K 0.02% 467
2024
Q2
$105K Buy
+5,100
New +$110K 0.03% 279

Other funds holding PRTA

Catalyst Funds Management's PRTA Position: Q4 2024 in Review

Catalyst Funds Management sold out of Prothena Corp (PRTA) in Q4 2024, closing a stake of 6,700 shares — an estimated $112K sold.

Catalyst Funds Management first reported a position in PRTA in Q2 2024 and held it in 2 quarters. The position peaked at $112K in Q3 2024. 170 funds tracked by Wall St. Rank hold PRTA as of Q4 2024.

  • Catalyst Funds Management reported no remaining Prothena Corp position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 6,700 Prothena Corp shares in Q4 2024, an estimated $112K.
  • Catalyst Funds Management first reported a position in Prothena Corp in Q2 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Prothena Corp position peaked at $112K in Q3 2024.
  • 170 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.